Matches in Wikidata for { <http://www.wikidata.org/entity/Q56004533> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q56004533 description "article scientifique publié en 1993" @default.
- Q56004533 description "article" @default.
- Q56004533 description "im März 1993 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56004533 description "wetenschappelijk artikel" @default.
- Q56004533 description "наукова стаття, опублікована в березні 1993" @default.
- Q56004533 description "ലേഖനം" @default.
- Q56004533 name "Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619" @default.
- Q56004533 name "Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619" @default.
- Q56004533 type Item @default.
- Q56004533 label "Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619" @default.
- Q56004533 label "Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619" @default.
- Q56004533 prefLabel "Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619" @default.
- Q56004533 prefLabel "Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619" @default.
- Q56004533 P1433 Q56004533-C3E5FD47-88C0-4673-88C3-AB4C94688E55 @default.
- Q56004533 P1476 Q56004533-48F3A7C3-3CCE-4B7B-8BC9-365B284CC6DE @default.
- Q56004533 P2093 Q56004533-5908CC03-0698-4598-9E1C-93DC8E542222 @default.
- Q56004533 P2093 Q56004533-B53D83AE-C25D-4540-AE86-FC419EF6E26C @default.
- Q56004533 P2093 Q56004533-B7B4F07A-3927-4F56-A489-0097AB81AC83 @default.
- Q56004533 P2093 Q56004533-C6DE0B03-6CD9-476F-8895-072F0B0EE77F @default.
- Q56004533 P304 Q56004533-C9BB5B90-4119-43D8-B8EF-075779FD7628 @default.
- Q56004533 P31 Q56004533-E3AF7274-9277-4F96-8300-E074F869DECD @default.
- Q56004533 P356 Q56004533-B6F0A85E-1F34-420C-A0E7-3120B99D8883 @default.
- Q56004533 P407 Q56004533-5B647894-3776-4A5D-9E68-CE9D9E58A9EC @default.
- Q56004533 P433 Q56004533-9AEBC878-1645-4A92-83B5-1D92F1CC7B5E @default.
- Q56004533 P478 Q56004533-B792066C-5EAF-49FF-89D9-58D5BEB98601 @default.
- Q56004533 P577 Q56004533-6CEC6BEB-E791-4FE8-AF6E-2CA3C0A57B38 @default.
- Q56004533 P5875 Q56004533-B5D1043A-57B6-4BF1-8B8E-FE4CA54362BC @default.
- Q56004533 P356 01.ATV.13.3.421 @default.
- Q56004533 P1433 Q4797542 @default.
- Q56004533 P1476 "Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619" @default.
- Q56004533 P2093 "D. Bachir" @default.
- Q56004533 P2093 "F. Galacteros" @default.
- Q56004533 P2093 "I. Foulon" @default.
- Q56004533 P2093 "J. Maclouf" @default.
- Q56004533 P304 "421-426" @default.
- Q56004533 P31 Q13442814 @default.
- Q56004533 P356 "10.1161/01.ATV.13.3.421" @default.
- Q56004533 P407 Q1860 @default.
- Q56004533 P433 "3" @default.
- Q56004533 P478 "13" @default.
- Q56004533 P577 "1993-03-01T00:00:00Z" @default.
- Q56004533 P5875 "14756457" @default.